Aubrey Kelly is CEO of RabbleHealth, a health technology and services company in Southern California. Aubrey is a 15-year pharmaceutical executive turned health-tech entrepreneur in 2020. She spent the last 15 years of her career at Amgen, the world’s largest biotechnology company. She led multiple strategy and innovation initiatives and was responsible for the Office of Commercialization Excellence. She has extensive experience in oncology, inflammation, and cardiovascular disorders improving access to clinical trials and driving life-cycle management strategies.

Aubrey’s son was diagnosed with Acute Myeloid Leukemia in 2017 and had a successful Bone Marrow Transplant at Children’s Hospital Los Angeles.

Her son’s experience, coupled with her passion to improve patient access inspired Ms. Kelly to create a patient engagement technology that decreases the burden of cancer. Aubrey is a member of the Board of Trustees at Children’s Hospital Los Angeles, and a Board Member at Make-A-Wish Tri Counties. She received her MS from the University of Colorado and her MBA from UCLA’s Anderson School of Management.